Glimirep 3/1000 MG Tablet 10

Glimirep 3/1000 MG Tablet 10 is used in the following conditions: 

• Improving blood sugar control in adults with type 2 diabetes mellitus
• Supporting diet and exercise efforts to manage type 2 diabetes in adults
• Helping to prevent post-meal blood sugar spikes in adults with type 2 diabetes

You should take Glimirep 3/1000 MG Tablet 10 in the following way: 

• Swallow the tablet whole with a glass of water.
• Avoid crushing, chewing, or splitting the tablet.
• Do not exceed the dose recommended by your doctor.
• Always consult your doctor before discontinuing this medication.

Glimirep 3/1000 MG Tablet 10 is taken orally. 

Glimirep 3/1000 MG Tablet 10 contains the following components:

• Glimepiride (3 Mg): As a sulfonylurea, glimepiride stimulates insulin release from active pancreatic beta cells by binding to receptors on their surface. This action increases intracellular calcium levels, which in turn triggers insulin secretion.
• Metformin (1000 Mg):  This biguanide lowers glucose production in the liver, reduces glucose absorption in the intestines, and enhances insulin sensitivity by improving peripheral glucose uptake and utilisation. It activates the enzyme AMPK in the liver to help regulate these processes.

The storage instructions for Glimirep 3/1000 MG Tablet 10 are as follows:

• Store this tablet at room temperature, around 25°C, and protect it from light and moisture.
• Keep out of reach of children and pets.
• Do not use this medication once its expiration date has passed.

• While taking Glimirep 3/1000 MG Tablet 10, maintain a balanced diet rich in whole grains, vegetables, and lean proteins to help regulate blood sugar levels. 
• Avoid high-sugar and high-carbohydrate foods, as they can spike blood glucose. Incorporate regular physical activity, such as walking or light exercise, to enhance insulin sensitivity. 
• Stay hydrated and limit alcohol intake to reduce complications. Consistently monitor your blood sugar levels and follow your doctor's recommendations.